NOT MEDICAL ADVICE

Argireline

Estimated Market Price
$64.99 $79.99
Based on verified supplier pricing for research-grade compounds
Topical anti-wrinkle peptide. Relaxes facial muscles to smooth expression lines without injections. Up to 30 percent wrinkle reduction in clinical trials.
How it works

Interferes with the SNARE complex that tells facial muscles to contract, relaxing expression lines similarly to Botox but with a gentler, non-paralytic effect that can be applied topically.

Skin & Beauty

What to Expect
Week 1–2 SNARE complex modulation begins; skin adjusting to peptide. Skin feels smoother where applied; subtle hydration.
Week 3–4 Expression lines softening; forehead and crow's feet improving. Forehead lines and crow's feet softening visibly.
Week 5–8 Significant wrinkle depth reduction visible; smoother texture. Friends asking if you got Botox; lines clearly reduced.
Week 9–12 Peak anti-wrinkle effect; continued use maintains results. Maintained smooth look with continued daily use.

Verified Suppliers

For research purposes only. These suppliers have been independently verified by PepSpace. We do not process sales directly.

PepSpace is not affiliated with any listed supplier
Protocol & Dosage
Typical Dosage Topical serum, 2x daily
Administration Topical
Schedule Morning and evening to clean, dry skin
Protocol Duration 4–12 weeks
Half-Life Topical application (not systemically absorbed)
Side Effects & Safety
Tolerability Profile Favorable

Very well tolerated; side effects are rare and mild

Common Side Effects

  • No common side effects reported

Less Common

  • Mild skin irritation at application siteoccasional
  • Temporary redness or itchingoccasional

Rare / Serious

  • Skin drynessrare

Discontinue If

  • Severe rash or allergic contact dermatitis
  • Persistent skin irritation

Contraindications

  • Known hypersensitivity to hexapeptides
  • Active skin infection at application site
  • Neuromuscular disorders (e.g., myasthenia gravis)

Data note: Topical neuropeptide with extensive cosmetic use history. Works by relaxing facial muscles (botox-like mechanism). Very well tolerated.

Always consult a qualified healthcare professional before use. This information is for research reference only and does not constitute medical advice.

Ask about Argireline
Send us a message

Call us
+1 (518) 327-4392
Business hours
Monday – Friday 9:00 AM – 6:00 PM EST
Saturday 10:00 AM – 2:00 PM EST
Sunday Closed

You can also reach us via or .

How to Apply

1

Gather

Peptide vial, BAC water, alcohol swabs, insulin syringe

2

Sanitize

Wipe tops of both vials with alcohol swabs

3

Draw

Pull 1–2 mL of BAC water into syringe

4

Add Water

Release water slowly along vial wall, not directly on powder

5

Swirl

Roll between palms until dissolved. Never shake.

6

Store

Refrigerate 2–8°C, use within 30 days

Frequently Asked Questions

Yes. Bacteriostatic water (BAC water) is required to reconstitute lyophilized (freeze-dried) peptides. It contains 0.9% benzyl alcohol which prevents bacterial growth, keeping your reconstituted peptide safe for multiple uses over up to 30 days.

Unreconstituted: store at -20°C (freezer) for long-term, or 2–8°C (fridge) for short-term. After reconstitution: always refrigerate at 2–8°C and use within 30 days. Keep away from direct sunlight.

Results vary by individual and protocol. In research settings, measurable effects are typically observed within 1–4 weeks depending on the specific peptide, dosage, and application. Consult a qualified professional for guidance.

Verified suppliers typically include a full third-party COA verifying purity (99%+), identity, and sterility. We recommend only sourcing from vendors that provide batch-specific testing data.

We list verified suppliers above that have been independently reviewed for product quality, testing transparency, and shipping reliability. Always verify COA data before sourcing.

Compound Profile

Scientific data & classification for Argireline

Also Known As Acetyl Hexapeptide-3, Acetyl Hexapeptide-8, Argireline®
Classification Hexapeptide · Anti-Wrinkle / Cosmetic
Sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂
Molecular Formula C₃₄H₆₀N₁₄O₁₂S
Molecular Weight 888.96 Da
CAS Number 616204-22-9
Half-Life Topical application (not systemically absorbed)
Origin Synthetic peptide mimicking the N-terminal of SNAP-25
Administration Topical
Status Commercially available - cosmetic ingredient
Mechanism of Action Interferes with the SNARE complex that tells facial muscles to contract, relaxing expression lines similarly to Botox but with a gentler, non-paralytic effect that can be applied topically.
Research Overview Argireline (Acetyl Hexapeptide-3 or Acetyl Hexapeptide-8) is a synthetic hexapeptide developed by the Spanish biotechnology company Lipotec (now part of Lubrizol) as a topical cosmeceutical alternative to botulinum toxin injections for the reduction of facial expression wrinkles. The peptide was designed based on the molecular mechanism of botulinum neurotoxin - specifically, it mimics the N-terminal sequence of SNAP-25 (synaptosomal-associated protein of 25 kDa), one of three proteins that form the SNARE complex responsible for vesicular neurotransmitter release at the neuromuscular junction. The SNARE complex consists of SNAP-25, syntaxin, and VAMP (synaptobrevin), which assemble into a four-helix bundle that provides the mechanical force for synaptic vesicle fusion with the presynaptic membrane. Botulinum toxin achieves its muscle-relaxing effect by enzymatically cleaving SNAP-25, permanently disabling the SNARE complex until new protein is synthesized. Argireline, in contrast, competes with native SNAP-25 for incorporation into the SNARE complex, forming a non-functional complex that partially inhibits acetylcholine release without destroying the protein. This competitive rather than destructive mechanism produces a milder, reversible reduction in muscle contraction intensity that softens dynamic expression wrinkles - particularly in the periorbital (crow's feet) and glabellar (frown lines) regions. Clinical studies published in the International Journal of Cosmetic Science demonstrated that a 10% Argireline solution applied twice daily for 30 days reduced wrinkle depth by approximately 30% as measured by silicon replica analysis, with some subjects achieving reductions approaching 50%. The peptide's efficacy is inherently limited by dermal penetration - unlike injected botulinum toxin which is delivered directly to the neuromuscular junction, topical Argireline must traverse the stratum corneum, epidermis, and dermis to reach target nerve endings, and only a fraction of the applied dose achieves effective concentrations at the site of action.

Citations

Published findings on Argireline from peer-reviewed journals.

Research Assistant
Hey, I'm the PepSpace research assistant. Ask me anything about peptides and I'll do my best to help.